Equities research analysts expect LifePoint Health Inc (NASDAQ:LPNT) to announce sales of $1.58 billion for the current quarter, Zacks Investment Research reports. Eleven analysts have provided estimates for LifePoint Health’s earnings. The highest sales estimate is $1.59 billion and the lowest is $1.57 billion. LifePoint Health reported sales of $1.59 billion during the same quarter last year, which would suggest a negative year over year growth rate of 0.6%. The business is scheduled to announce its next quarterly earnings report on Tuesday, August 7th.
According to Zacks, analysts expect that LifePoint Health will report full year sales of $6.34 billion for the current financial year, with estimates ranging from $6.28 billion to $6.38 billion. For the next fiscal year, analysts forecast that the company will report sales of $6.49 billion per share, with estimates ranging from $6.38 billion to $6.64 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for LifePoint Health.
LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Friday, May 4th. The company reported $1.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.13 by $0.09. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.62 billion. LifePoint Health had a net margin of 0.48% and a return on equity of 6.56%. The company’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period in the prior year, the business earned $1.07 EPS.
A number of hedge funds have recently added to or reduced their stakes in the business. Point72 Asia Hong Kong Ltd boosted its stake in shares of LifePoint Health by 1,897.5% during the first quarter. Point72 Asia Hong Kong Ltd now owns 2,417 shares of the company’s stock valued at $114,000 after purchasing an additional 2,296 shares during the period. State of Alaska Department of Revenue acquired a new position in LifePoint Health in the 4th quarter valued at $134,000. US Bancorp DE raised its stake in LifePoint Health by 62.4% in the 4th quarter. US Bancorp DE now owns 3,095 shares of the company’s stock valued at $155,000 after purchasing an additional 1,189 shares during the last quarter. Xact Kapitalforvaltning AB acquired a new position in LifePoint Health in the 4th quarter valued at $230,000. Finally, Verition Fund Management LLC acquired a new position in LifePoint Health in the 1st quarter valued at $224,000.
Shares of LifePoint Health traded up $0.45, hitting $55.00, during trading hours on Thursday, according to MarketBeat. 479,371 shares of the stock were exchanged, compared to its average volume of 334,693. The company has a current ratio of 1.76, a quick ratio of 1.55 and a debt-to-equity ratio of 1.28. The firm has a market capitalization of $2.13 billion, a price-to-earnings ratio of 14.67, a P/E/G ratio of 1.41 and a beta of 0.51. LifePoint Health has a 1-year low of $41.45 and a 1-year high of $67.95.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.